<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201407228717N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2014-08-23</date_registration>
      <primary_sponsor>Vice chancellor for research and technology, Semnan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of electroacupressure on motor function and muscular power of pelagic upper extremity in patient with stroke</public_title>
      <acronym>-</acronym>
      <scientific_title>The effect of electroacupressure on motor function and muscular power of pelagic upper extremity in patient with stroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2014-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/9214</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Other design features: In this study, subjects are assigned randomly and using the randomized block to the experimental, placebo, and controll groups.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Stroke.</hc_freetext>
      <i_freetext>Intervention 1: First intervention (Routine care): In the control group patients receive routine care, after the doctor's orders to start physiotherapy, routine physiotherapy is performed for all patients. motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer. Intervention 2: The second intervention (use of electroacupressure): In the intervention group, to applying the electroacupressure, the wristbands is closed on patients’ wrists so that its button is placed on the P6 point (Nei guan) on the inner surface of the forearm, about 2 inches (three fingers width) above the internal groove of wrist. Pressure is applied so that the patient does not feel pain or discomfort. Electrical stimulation is applied with wave length 200μs, frequency 20Hz, and intensity 2.5 times the threshold of patient sense by a metal button attached to the active electrode of TENS devices on the P6 (Neiguan) point. The intervention is performed for 10 minutes immediately after physiotherapy, five days per week and during two consecutive weeks. Motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer. Intervention 3: The third intervention (use of placebo): In the intervention group using placebo, wristbands is closed on patients’ wrists so that its button is placed on opposite of P6 point (Nei guan) on the back of the forearm. Active electrode (positive) of TENS device is connected to the metal buttons, device is turned on but does not give electrical stimulation. The intervention is performed for 10 minutes immediately after physiotherapy, five days per week and during two consecutive weeks. Motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Mohammad Reza Asgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of nursing and allied, Semnan University of Medical Sciences, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514743365</zip>
        <telephone>+98 23 3345 3365</telephone>
        <email>asgari5000@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>ِDr. Mohammad Reza Asgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of nursing and allied, Semnan University of Medical Sciences, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3514743365</zip>
        <telephone>+98 23 3345 3365</telephone>
        <email>asgari5000@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: (1) being over 35 years old; (2) Upper extremity paralysis due to stroke; (3) No other musculoskeletal disorders on the upper limb; (4) Patients with cognitive status so that they could have cooperated; (5) having no skin problem such as allergies and ulcers at the wrist strap site; (6) physiotherapy should be started for them; (7) maximum a week passed they strokes; (8) no recurrent stroke; (9) the patient did not receive thrombolytic drugs; (10) not in cerebellum and brain stem stroke; (11) is not revarsible ischemic neurologic deficit (RIND). Exclusion criteria: (1) Patients with cardiac pacemakers; (2) Patients with sensory aphasia; (3) Patients with a history of drug addiction.</inclusion_criteria>
      <agemin>35 years</agemin>
      <agemax>90 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>164</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stroke</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention (Routine care): In the control group patients receive routine care, after the doctor's orders to start physiotherapy, routine physiotherapy is performed for all patients. motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer.</i_keyword>
      <i_keyword>The second intervention (use of electroacupressure): In the intervention group, to applying the electroacupressure, the wristbands is closed on patients’ wrists so that its button is placed on the P6 point (Nei guan) on the inner surface of the forearm, about 2 inches (three fingers width) above the internal groove of wrist. Pressure is applied so that the patient does not feel pain or discomfort. Electrical stimulation is applied with wave length 200μs, frequency 20Hz, and intensity 2.5 times the threshold of patient sense by a metal button attached to the active electrode of TENS devices on the P6 (Neiguan) point. The intervention is performed for 10 minutes immediately after physiotherapy, five days per week and during two consecutive weeks. Motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer.</i_keyword>
      <i_keyword>The third intervention (use of placebo): In the intervention group using placebo, wristbands is closed on patients’ wrists so that its button is placed on opposite of P6 point (Nei guan) on the back of the forearm. Active electrode (positive) of TENS device is connected to the metal buttons, device is turned on but does not give electrical stimulation. The intervention is performed for 10 minutes immediately after physiotherapy, five days per week and during two consecutive weeks. Motor function and muscular power of pelagic upper extremity are measured by researcher before start intervention at the first session and after the intervention at the last session by using Fugl Meyer checklist and manually dynamometer.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Motor function of pelagic upper extremity. Timepoint: Before start intervention at the first session and after the intervention at the last session. Method of measurement: Part of evaluation of upper limb motor function and Hand of Fugl Meyer scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Muscular power of pelagic upper extremity. Timepoint: Before start intervention at the first session and After the intervention, at the last session. Method of measurement: By manually dynamometer.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research and technology, Semnan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2014-07-08</approval_date>
        <contact_name>Ethics committee in biomedical researches of Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan University of Medical Sciences, Semnan, Semnan Province, Iran Semnan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
